DOCSLIB.ORG

Identification of Candidate Biomarkers and Prognostic Analysis In

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

ORIGINAL RESEARCH published: 04 August 2021 doi: 10.3389/fonc.2021.652354 Identification of Candidate Biomarkers and Prognostic Analysis in Colorectal Cancer Liver Metastases † † Tianhao Zhang , Kaitao Yuan , Yingzhao Wang, Mingze Xu, Shirong Cai, Chuangqi Chen and Jinping Ma* Division of Gastrointestinal Surgery Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China Background: Colorectal cancer (CRC), one of the most common malignant tumors worldwide, has a high mortality rate, especially for patients with CRC liver metastasis (CLM). However, CLM pathogenesis remains unclear. Methods: We integrated multiple cohort datasets and databases to clarify and verify Edited by: potential key candidate biomarkers and signal transduction pathways in CLM. GEO2R, Zsolt Kova´ cs, DAVID 6.8, ImageGP, STRING, UALCAN, ONCOMINE, THE HUMAN PROTEIN ATLAS, George Emil Palade University of Medicine, Pharmacy, Sciences and GEPIA 2.0, cBioPortal, TIMER 2.0, DRUGSURV, CRN, GSEA 4.0.3, FUNRICH 3.1.3 and Technology of Taˆ rgu Mures¸, Romania R 4.0.3 were utilized in this study. Reviewed by: Results: Sixty-three pairs of matched colorectal primary cancer and liver metastatic gene Tomas Kazda, Masaryk Memorial Cancer Institute expression profiles were screened from three gene expression profiles (GSE6988, (MMCI), Czechia GSE14297 and GSE81558). Thirty-one up-regulated genes and four down-regulated Louise Catherine Connell, fi fi fi Cornell University, United States genes were identi ed from these three gene expression pro les and veri ed by another fi *Correspondence: gene expression pro les (GSE 49355) and TCGA database. Two pathways (IGFBP-IGF Jinping Ma signaling pathway and complement-coagulation cascade), eighteen key differentially [email protected] expressed genes (DEGs), six hub genes (SPARCL1, CDH2, CP, HP, TF and † These authors share first authorship SERPINA5) and two biomarkers (CDH2 and SPARCL1) with significantly prognostic fi Specialty section: values were screened by multi-omics data analysis and veri ed by Gene Expression This article was submitted to Omnibus (GEO) and The Cancer Genome Atlas (TCGA) cohort. Gastrointestinal Cancers, fi a section of the journal Conclusions: In this study, we identi ed a robust set of potential candidate biomarkers in Frontiers in Oncology CLM, which would provide potential value for early diagnosis and prognosis, and would Received: 12 January 2021 promote molecular targeting therapy for CRC and CLM. Accepted: 19 July 2021 Published: 04 August 2021 Keywords: colorectal cancer, differentially expressed genes, liver metastasis, biomarkers, prognostic analysis Citation: Zhang T, Yuan K, Wang Y, Xu M, Cai S, Chen C and Ma J (2021) Abbreviations: AI, Artificial Intelligence; CLM, Colorectal Cancer Liver Metastasis; COAD, Colon Adenocarcinoma; CRC, Identification of Candidate Biomarkers Colorectal Cancer; DEG, Differentially Expressed Genes; DFS, Disease-Free Survival; GEO, Gene Expression Omnibus; GO, and Prognostic Analysis in Colorectal Gene Ontology; GSEA, Gene Set Enrichment Analysis; IGF, Insulin-like Growth Factor; IGFBPs, Insulin-like Growth Factor- Cancer Liver Metastases. Binding Protein 1; KEGG, Kyoto Encyclopedia of Genes and Genomes; LIHC, Liver Hepatocellular Carcinoma; NGS, Next Front. Oncol. 11:652354. Generation Sequence; OS, Overall Survival; PPI, Protein-protein Interaction Network; READ, Rectal Adenocarcinoma; TCGA, doi: 10.3389/fonc.2021.652354 The Cancer Genome Atlas; TME, Tumor Microenvironment; TIMER, Tumor Immune Estimation Resource. Frontiers in Oncology | www.frontiersin.org 1 August 2021 | Volume 11 | Article 652354 Zhang et al. Biomarkers in Colorectal Cancer INTRODUCTION MATERIALS AND METHODS Colorectal cancer (CRC) is one of the most common malignant NCBI-GEO tumors worldwide. According to global cancer statistics, more than NCBI-GEO (Gene Expression Omnibus) (https://www.ncbi.nlm. 1.9 million new CRC cases and 935,000 deaths were reported in nih.gov/geo) is a free microarray/gene profile and NGS database. In 2020, accounting for approximately one-tenth of cancer cases and our study, we screened GSE6988 (5), GSE14297 (6), and GSE81558 deaths. Overall, the incidence of CRC ranks third globally, and the (7) microarray datasets containing expression profiles of matching mortality rate ranks second (1). Colorectal cancer liver metastasis colorectal liver metastases (primary colon cancer samples and liver (CLM) is one of the primary causes of this high mortality rate, metastasis samples of the same patient), and 63 pairs of matching which occurs in 30% of CRC patients, accounting for two-thirds of primary CRC and liver metastatic cancer tissues were used. To the related deaths (2). Further, more than 50% of patients relapse confirm the reliability of DEGs identified from the three GSE within 2 years after CLM resection (3). datasets, this study selected the GSE49355 (8) microarray dataset, Numerous clinical data indicate that the liver is the most which includes 13 pairs of matched primary colorectal cancer and common target organ for CRC metastasis. To date, the relevant liver metastasis samples, in the GEO database for verification. mechanisms underlying the formation and progression of liver metastasis during disease progression of this disease have been GEO2R extensively studied, however, the pathogenesis has not been fully GEO2R (https://www.ncbi.nlm.nih.gov/geo/geo2r/), is a data elucidated. With the rise of emerging technologies such as genome processing tool on GEO. Statistically significant differences were and transcriptome sequencing, gene-editing technology, and identified based on a classic t-test, considering p < 0.05 and artificial intelligence (AI), biomedical research is undergoing |log FC| > 1 as the cut-off criteria. In this study, we used GEO2R revolutionary changes, gradually transforming from traditional to filter the original data to determine DEGs and visualized them with medicine to precision medicine. Among them, next-generation SANGERBOX (http://sangerbox.com/Index), FUNRICH and R. sequencing (NGS) technology has revolutionized our ability to obtain information from the genome regarding the DNA DAVID sequence itself, as well as the state of the transcriptome and the Database for Annotation, Visualization and Integrated Discovery epigenome (4). However, most NGS technologies have not solved (DAVID) 6.8 (https://david.ncifcrf.gov/home.jsp) is a the functional interpretation of differentially expressed genes comprehensive, functional annotation website that help (DEGs) to identify appropriate key genes. Indeed, the occurrence investigators better clarify the biological function of submitted and development of CLM involves a myriad of epigenetic and genes (9). In our study, the Gene Ontology (GO) enrichment genetic changes within multiple functional signaling pathways. analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) These different networks are susceptible to regulation by genetic pathway enrichment analysis of DEGs were isolated from DAVID and epigenetic events, leading to diversity in the expression profiles. 6.8 and visualized with EHbio (http://www.ehbio.com/ImageGP/ Therefore, the combination of integrated bioinformatics methods index.php/home/index/scatterplot.html). Biological processes and expression profiling technology may have the ability to (BP), cellular components (CC) and molecular function (MF) overcome, thus screening suitable biomarkers and guiding the were included in GO enrichment analysis. selection of clinical systemic prevention, diagnostic, and treatment options. STRING In this study, we aimed to analyze and predict candidate STRING (https://string-db.org/) aims to collect, score, and integrate biomarkers of CLM. Firstly, key DEGs were screened from gene all publicly available sources of protein-protein interaction (PPI) expression profiles of GEO database (Gene Expression Omnibus). data and complement these with computational predictions of Specifically, we identified the biological functions and signal potential functions (10). We used STRING to develop and transduction pathways of the selected DEGs through GO (Gene construct DEG-encoded proteins and PPI networks and analyze ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) the interactions among candidate DEG-encoded proteins, and we enrichment analysis. Further, we constructed protein-protein visualized them with CYTOSCAPE 3.7.2. interaction (PPI) networks and analyzed prognostic values of candidate genes in CRC through data mining. Finally, to evaluate UALCAN whether the selected candidate biomarkers are reliable, we analyzed UALCAN (http://ualcan.path.uab.edu/analysis.html), a thegeneexpressionprofile data sets, RNA-Seq data sets of GEO and comprehensive web resource, provides analyses based on The TCGA databases, and used CNV (copy number variation), GESA Cancer Genome Atlas (TCGA) and MET500 cohort data (11). In (Gene Set Enrichment Analysis), IHC (immunohistochemistry), this study, we used UALCAN to analyze the expression profiles and other methods for verification. Moreover, the verification and prognostic values of DEGs. Student’s t-test was used to results are basically consistent with our research conclusions. generate a p-value. The p-value cutoff was 0.05. Therefore, this study will contribute to understanding the molecular mechanism in depth and contribute to the discovery of ONCOMINE new appropriate molecular diagnostic and therapeutic targets, and ONCOMINE (www.oncomine.org), currently the world’s largest more accurately prognose long term outcome
Recommended publications
  • Frequent Expression Loss of Inter-Alpha-Trypsin Inhibitor Heavy Chain (ITIH) Genes in Multiple Human Solid Tumors: a Systematic Expression Analysis

    Frequent Expression Loss of Inter-Alpha-Trypsin Inhibitor Heavy Chain (ITIH) Genes in Multiple Human Solid Tumors: a Systematic Expression Analysis

    Hamm, A; Veeck, J; Bektas, N; Wild, P J; Hartmann, A; Heindrichs, U; Kristiansen, G; Werbowetski-Ogilvie, T; Del Maestro, R; Knuechel, R; Dahl, E (2008). Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis. BMC Cancer, 8:25. Postprint available at: http://www.zora.uzh.ch University of Zurich Posted at the Zurich Open Repository and Archive, University of Zurich. Zurich Open Repository and Archive http://www.zora.uzh.ch Originally published at: BMC Cancer 2008, 8:25. Winterthurerstr. 190 CH-8057 Zurich http://www.zora.uzh.ch Year: 2008 Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis Hamm, A; Veeck, J; Bektas, N; Wild, P J; Hartmann, A; Heindrichs, U; Kristiansen, G; Werbowetski-Ogilvie, T; Del Maestro, R; Knuechel, R; Dahl, E Hamm, A; Veeck, J; Bektas, N; Wild, P J; Hartmann, A; Heindrichs, U; Kristiansen, G; Werbowetski-Ogilvie, T; Del Maestro, R; Knuechel, R; Dahl, E (2008). Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis. BMC Cancer, 8:25. Postprint available at: http://www.zora.uzh.ch Posted at the Zurich Open Repository and Archive, University of Zurich. http://www.zora.uzh.ch Originally published at: BMC Cancer 2008, 8:25. Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis Abstract BACKGROUND: The inter-alpha-trypsin inhibitors (ITI) are a family of plasma protease inhibitors, assembled from a light chain - bikunin, encoded by AMBP - and five homologous heavy chains (encoded by ITIH1, ITIH2, ITIH3, ITIH4, and ITIH5), contributing to extracellular matrix stability by covalent linkage to hyaluronan.
  • Supplementary Information Changes in the Plasma Proteome At

    Supplementary Information Changes in the Plasma Proteome At

    Supplementary Information Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer’s disease Julia Muenchhoff1, Anne Poljak1,2,3, Anbupalam Thalamuthu1, Veer B. Gupta4,5, Pratishtha Chatterjee4,5,6, Mark Raftery2, Colin L. Masters7, John C. Morris8,9,10, Randall J. Bateman8,9, Anne M. Fagan8,9, Ralph N. Martins4,5,6, Perminder S. Sachdev1,11,* Supplementary Figure S1. Ratios of proteins differentially abundant in asymptomatic carriers of PSEN1 and APP Dutch mutations. Mean ratios and standard deviations of plasma proteins from asymptomatic PSEN1 mutation carriers (PSEN1) and APP Dutch mutation carriers (APP) relative to reference masterpool as quantified by iTRAQ. Ratios that significantly differed are marked with asterisks (* p < 0.05; ** p < 0.01). C4A, complement C4-A; AZGP1, zinc-α-2-glycoprotein; HPX, hemopexin; PGLYPR2, N-acetylmuramoyl-L-alanine amidase isoform 2; α2AP, α-2-antiplasmin; APOL1, apolipoprotein L1; C1 inhibitor, plasma protease C1 inhibitor; ITIH2, inter-α-trypsin inhibitor heavy chain H2. 2 A) ADAD)CSF) ADAD)plasma) B) ADAD)CSF) ADAD)plasma) (Ringman)et)al)2015)) (current)study)) (Ringman)et)al)2015)) (current)study)) ATRN↓,%%AHSG↑% 32028% 49% %%%%%%%%HC2↑,%%ApoM↓% 24367% 31% 10083%% %%%%TBG↑,%%LUM↑% 24256% ApoC1↓↑% 16565% %%AMBP↑% 11738%%% SERPINA3↓↑% 24373% C6↓↑% ITIH2% 10574%% %%%%%%%CPN2↓%% ↓↑% %%%%%TTR↑% 11977% 10970% %SERPINF2↓↑% CFH↓% C5↑% CP↓↑% 16566% 11412%% 10127%% %%ITIH4↓↑% SerpinG1↓% 11967% %%ORM1↓↑% SerpinC1↓% 10612% %%%A1BG↑%%% %%%%FN1↓% 11461% %%%%ITIH1↑% C3↓↑% 11027% 19325% 10395%% %%%%%%HPR↓↑% HRG↓% %%% 13814%% 10338%% %%% %ApoA1 % %%%%%%%%%GSN↑% ↓↑ %%%%%%%%%%%%ApoD↓% 11385% C4BPA↓↑% 18976%% %%%%%%%%%%%%%%%%%ApoJ↓↑% 23266%%%% %%%%%%%%%%%%%%%%%%%%%%ApoA2↓↑% %%%%%%%%%%%%%%%%%%%%%%%%%%%%A2M↓↑% IGHM↑,%%GC↓↑,%%ApoB↓↑% 13769% % FGA↓↑,%%FGB↓↑,%%FGG↓↑% AFM↓↑,%%CFB↓↑,%% 19143%% ApoH↓↑,%%C4BPA↓↑% ApoA4↓↑%%% LOAD/MCI)plasma) LOAD/MCI)plasma) LOAD/MCI)plasma) LOAD/MCI)plasma) (Song)et)al)2014)) (Muenchhoff)et)al)2015)) (Song)et)al)2014)) (Muenchhoff)et)al)2015)) Supplementary Figure S2.
  • The Oviductal Transcriptome Is Influenced by a Local Ovarian Effect in the Sow Rebeca López-Úbeda1,2, Marta Muñoz3, Luis Vieira1,2, Ronald H

    The Oviductal Transcriptome Is Influenced by a Local Ovarian Effect in the Sow Rebeca López-Úbeda1,2, Marta Muñoz3, Luis Vieira1,2, Ronald H

    López-Úbeda et al. Journal of Ovarian Research (2016) 9:44 DOI 10.1186/s13048-016-0252-9 RESEARCH Open Access The oviductal transcriptome is influenced by a local ovarian effect in the sow Rebeca López-Úbeda1,2, Marta Muñoz3, Luis Vieira1,2, Ronald H. F. Hunter4, Pilar Coy1,2,5* and Sebastian Canovas1,2,5* Abstract Background: Oviducts participate in fertilization and early embryo development, and they are influenced by systemic and local circulation. Local functional interplay between ovary, oviduct and uterus is important, as deduced from the previously observed differences in hormone concentrations, presence of sperm, or patterns of motility in the oviduct after unilateral ovariectomy (UO). However, the consequences of unilateral ovariectomy on the oviductal transcriptome remain unexplored. In this study, we have investigated the consequences of UO in a higher animal model as the pig. Methods: The influence of UO was analyzed on the number of ovulations on the contra ovary, which was increased, and on the ipsilateral oviductal transcriptome. Microarray analysis was performed and the results were validated by PCR. Differentially expressed genes (DEGs) with a fold change ≥ 2andafalsediscoveryrateof10%were analyzed by Ingenuity Pathway Analysis (IPA) to identify the main biofunctions affected by UO. Results: Data revealed two principal effects in the ipsilateral oviduct after UO: i) down-regulation of genes involved in the survival of sperm in the oviduct and early embryonic development, and ii) up-regulation of genes involved in others functions as protection against external agents and tumors. Conclusions: Results showed that unilateral ovariectomy results in an increased number of ovulation points on the contra ovary and changes in the transcriptome of the ipsilateral oviduct with consequences on key biological process that could affect fertility output.
  • Anti-HABP2 Monoclonal Antibody, Clone FQS25662 (DCABH-7346) This Product Is for Research Use Only and Is Not Intended for Diagnostic Use

    Anti-HABP2 Monoclonal Antibody, Clone FQS25662 (DCABH-7346) This Product Is for Research Use Only and Is Not Intended for Diagnostic Use

    Anti-HABP2 monoclonal antibody, clone FQS25662 (DCABH-7346) This product is for research use only and is not intended for diagnostic use. PRODUCT INFORMATION Product Overview Rabbit monoclonal to HABP2 Antigen Description Cleaves the alpha-chain at multiple sites and the beta-chain between Lys-53 and Lys-54 but not the gamma-chain of fibrinogen and therefore does not initiate the formation of the fibrin clot and does not cause the fibrinolysis directly. It does not cleave (activate) prothrombin and plasminogen but converts the inactive single chain urinary plasminogen activator (pro-urokinase) to the active two chain form. Activates coagulation factor VII. Immunogen Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human HABP2 aa 350-450. The exact sequence is proprietary.Database link: Q14520 Isotype IgG Source/Host Rabbit Species Reactivity Mouse, Rat, Human Clone FQS25662 Purity Tissue culture supernatant Conjugate Unconjugated Applications WB, IHC-P, ICC/IF Positive Control Human fetal liver, HepG2, MCF-7 and A549 lysate. Rat liver tissue. HepG2 cells. Format Liquid Size 100 μl Buffer Preservative: 0.01% Sodium azide; Constituents: 40% Glycerol, 59% PBS, 0.05% BSA Preservative 0.01% Sodium Azide Storage Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. Ship Shipped at 4°C. 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 1 © Creative Diagnostics All Rights Reserved
  • Supplementary Materials

    Supplementary Materials

    Supplementary materials Supplementary Table S1: MGNC compound library Ingredien Molecule Caco- Mol ID MW AlogP OB (%) BBB DL FASA- HL t Name Name 2 shengdi MOL012254 campesterol 400.8 7.63 37.58 1.34 0.98 0.7 0.21 20.2 shengdi MOL000519 coniferin 314.4 3.16 31.11 0.42 -0.2 0.3 0.27 74.6 beta- shengdi MOL000359 414.8 8.08 36.91 1.32 0.99 0.8 0.23 20.2 sitosterol pachymic shengdi MOL000289 528.9 6.54 33.63 0.1 -0.6 0.8 0 9.27 acid Poricoic acid shengdi MOL000291 484.7 5.64 30.52 -0.08 -0.9 0.8 0 8.67 B Chrysanthem shengdi MOL004492 585 8.24 38.72 0.51 -1 0.6 0.3 17.5 axanthin 20- shengdi MOL011455 Hexadecano 418.6 1.91 32.7 -0.24 -0.4 0.7 0.29 104 ylingenol huanglian MOL001454 berberine 336.4 3.45 36.86 1.24 0.57 0.8 0.19 6.57 huanglian MOL013352 Obacunone 454.6 2.68 43.29 0.01 -0.4 0.8 0.31 -13 huanglian MOL002894 berberrubine 322.4 3.2 35.74 1.07 0.17 0.7 0.24 6.46 huanglian MOL002897 epiberberine 336.4 3.45 43.09 1.17 0.4 0.8 0.19 6.1 huanglian MOL002903 (R)-Canadine 339.4 3.4 55.37 1.04 0.57 0.8 0.2 6.41 huanglian MOL002904 Berlambine 351.4 2.49 36.68 0.97 0.17 0.8 0.28 7.33 Corchorosid huanglian MOL002907 404.6 1.34 105 -0.91 -1.3 0.8 0.29 6.68 e A_qt Magnogrand huanglian MOL000622 266.4 1.18 63.71 0.02 -0.2 0.2 0.3 3.17 iolide huanglian MOL000762 Palmidin A 510.5 4.52 35.36 -0.38 -1.5 0.7 0.39 33.2 huanglian MOL000785 palmatine 352.4 3.65 64.6 1.33 0.37 0.7 0.13 2.25 huanglian MOL000098 quercetin 302.3 1.5 46.43 0.05 -0.8 0.3 0.38 14.4 huanglian MOL001458 coptisine 320.3 3.25 30.67 1.21 0.32 0.9 0.26 9.33 huanglian MOL002668 Worenine
  • Role and Regulation of the P53-Homolog P73 in the Transformation of Normal Human Fibroblasts

    Role and Regulation of the P53-Homolog P73 in the Transformation of Normal Human Fibroblasts

    Role and regulation of the p53-homolog p73 in the transformation of normal human fibroblasts Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Bayerischen Julius-Maximilians-Universität Würzburg vorgelegt von Lars Hofmann aus Aschaffenburg Würzburg 2007 Eingereicht am Mitglieder der Promotionskommission: Vorsitzender: Prof. Dr. Dr. Martin J. Müller Gutachter: Prof. Dr. Michael P. Schön Gutachter : Prof. Dr. Georg Krohne Tag des Promotionskolloquiums: Doktorurkunde ausgehändigt am Erklärung Hiermit erkläre ich, dass ich die vorliegende Arbeit selbständig angefertigt und keine anderen als die angegebenen Hilfsmittel und Quellen verwendet habe. Diese Arbeit wurde weder in gleicher noch in ähnlicher Form in einem anderen Prüfungsverfahren vorgelegt. Ich habe früher, außer den mit dem Zulassungsgesuch urkundlichen Graden, keine weiteren akademischen Grade erworben und zu erwerben gesucht. Würzburg, Lars Hofmann Content SUMMARY ................................................................................................................ IV ZUSAMMENFASSUNG ............................................................................................. V 1. INTRODUCTION ................................................................................................. 1 1.1. Molecular basics of cancer .......................................................................................... 1 1.2. Early research on tumorigenesis ................................................................................. 3 1.3. Developing
  • Mass Spectrometry Discovery-Based Proteomics to Examine Anti-Aging Effects of the Nutraceutical NT-020 in Rat Serum" (2020)

    Mass Spectrometry Discovery-Based Proteomics to Examine Anti-Aging Effects of the Nutraceutical NT-020 in Rat Serum" (2020)

    University of South Florida Scholar Commons Graduate Theses and Dissertations Graduate School March 2020 Mass Spectrometry Discovery-Based Proteomics to Examine Anti- Aging Effects of the Nutraceutical NT-020 in Rat Serum Samantha M. Portis University of South Florida Follow this and additional works at: https://scholarcommons.usf.edu/etd Part of the Bioinformatics Commons, and the Neurosciences Commons Scholar Commons Citation Portis, Samantha M., "Mass Spectrometry Discovery-Based Proteomics to Examine Anti-Aging Effects of the Nutraceutical NT-020 in Rat Serum" (2020). Graduate Theses and Dissertations. https://scholarcommons.usf.edu/etd/8279 This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact [email protected]. Mass Spectrometry Discovery-Based Proteomics to Examine Anti-Aging Effects of the Nutraceutical NT-020 in Rat Serum by Samantha M. Portis A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Medical Sciences with a concentration in Neuroscience Department of Molecular Pharmacology and Physiology College of Medicine University of South Florida Major Professor: Paul R. Sanberg, Ph.D., D.Sc Co-Major Professor: Paula C. Bickford, Ph.D. Kevin Nash, Ph.D. Dominic D’Agostino, Ph.D. Brent Small, Ph.D. Date of Approval: March 28, 2020 Keywords: aging, proteome, serum, inflammation, bioinformatics Copyright © 2020, Samantha M. Portis Dedication I dedicate this work to my family, Alan, Candace, Carolyn, and Jimmy, my brother, Patrick, and my partner, Will.
  • Nº Ref Uniprot Proteína Péptidos Identificados Por MS/MS 1 P01024

    Nº Ref Uniprot Proteína Péptidos Identificados Por MS/MS 1 P01024

    Document downloaded from http://www.elsevier.es, day 26/09/2021. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited. Nº Ref Uniprot Proteína Péptidos identificados 1 P01024 CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 por 162MS/MS 2 P02751 FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 131 3 P01023 A2MG_HUMAN Alpha-2-macroglobulin OS=Homo sapiens GN=A2M PE=1 SV=3 128 4 P0C0L4 CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 95 5 P04275 VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 81 6 P02675 FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 78 7 P01031 CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 66 8 P02768 ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 66 9 P00450 CERU_HUMAN Ceruloplasmin OS=Homo sapiens GN=CP PE=1 SV=1 64 10 P02671 FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 58 11 P08603 CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 56 12 P02787 TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 54 13 P00747 PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 48 14 P02679 FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 47 15 P01871 IGHM_HUMAN Ig mu chain C region OS=Homo sapiens GN=IGHM PE=1 SV=3 41 16 P04003 C4BPA_HUMAN C4b-binding protein alpha chain OS=Homo sapiens GN=C4BPA PE=1 SV=2 37 17 Q9Y6R7 FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 30 18 O43866 CD5L_HUMAN CD5 antigen-like OS=Homo
  • Genome-Wide Expression Profiling Establishes Novel Modulatory Roles

    Genome-Wide Expression Profiling Establishes Novel Modulatory Roles

    Batra et al. BMC Genomics (2017) 18:252 DOI 10.1186/s12864-017-3635-4 RESEARCHARTICLE Open Access Genome-wide expression profiling establishes novel modulatory roles of vitamin C in THP-1 human monocytic cell line Sakshi Dhingra Batra, Malobi Nandi, Kriti Sikri and Jaya Sivaswami Tyagi* Abstract Background: Vitamin C (vit C) is an essential dietary nutrient, which is a potent antioxidant, a free radical scavenger and functions as a cofactor in many enzymatic reactions. Vit C is also considered to enhance the immune effector function of macrophages, which are regarded to be the first line of defence in response to any pathogen. The THP- 1 cell line is widely used for studying macrophage functions and for analyzing host cell-pathogen interactions. Results: We performed a genome-wide temporal gene expression and functional enrichment analysis of THP-1 cells treated with 100 μM of vit C, a physiologically relevant concentration of the vitamin. Modulatory effects of vitamin C on THP-1 cells were revealed by differential expression of genes starting from 8 h onwards. The number of differentially expressed genes peaked at the earliest time-point i.e. 8 h followed by temporal decline till 96 h. Further, functional enrichment analysis based on statistically stringent criteria revealed a gamut of functional responses, namely, ‘Regulation of gene expression’, ‘Signal transduction’, ‘Cell cycle’, ‘Immune system process’, ‘cAMP metabolic process’, ‘Cholesterol transport’ and ‘Ion homeostasis’. A comparative analysis of vit C-mediated modulation of gene expression data in THP-1cells and human skin fibroblasts disclosed an overlap in certain functional processes such as ‘Regulation of transcription’, ‘Cell cycle’ and ‘Extracellular matrix organization’, and THP-1 specific responses, namely, ‘Regulation of gene expression’ and ‘Ion homeostasis’.
  • Single Cell Analysis of Human Foetal Liver Captures the Transcriptional Profile of Hepatobiliary Hybrid Progenitors

    Single Cell Analysis of Human Foetal Liver Captures the Transcriptional Profile of Hepatobiliary Hybrid Progenitors

    ARTICLE https://doi.org/10.1038/s41467-019-11266-x OPEN Single cell analysis of human foetal liver captures the transcriptional profile of hepatobiliary hybrid progenitors Joe M. Segal 1,8, Deniz Kent1,8, Daniel J. Wesche2,3, Soon Seng Ng 1, Maria Serra1, Bénédicte Oulès 1, Gozde Kar4, Guy Emerton4, Samuel J.I. Blackford 1, Spyros Darmanis5, Rosa Miquel1, Tu Vinh Luong1, Ryo Yamamoto2, Andrew Bonham2, Wayel Jassem6, Nigel Heaton6, Alessandra Vigilante1, Aileen King7, Rocio Sancho 1, Sarah Teichmann 4, Stephen R. Quake5,9, Hiromitsu Nakauchi2,9 & S. Tamir Rashid1,2,9 1234567890():,; The liver parenchyma is composed of hepatocytes and bile duct epithelial cells (BECs). Controversy exists regarding the cellular origin of human liver parenchymal tissue generation during embryonic development, homeostasis or repair. Here we report the existence of a hepatobiliary hybrid progenitor (HHyP) population in human foetal liver using single-cell RNA sequencing. HHyPs are anatomically restricted to the ductal plate of foetal liver and maintain a transcriptional profile distinct from foetal hepatocytes, mature hepatocytes and mature BECs. In addition, molecular heterogeneity within the EpCAM+ population of freshly isolated foetal and adult human liver identifies diverse gene expression signatures of hepatic and biliary lineage potential. Finally, we FACS isolate foetal HHyPs and confirm their hybrid progenitor phenotype in vivo. Our study suggests that hepatobiliary progenitor cells pre- viously identified in mice also exist in humans, and can be distinguished from other par- enchymal populations, including mature BECs, by distinct gene expression profiles. 1 Centre for Stem Cells and Regenerative Medicine & Institute for Liver Studies, King’s College London, London WC2R 2LS, UK.
  • Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid Cancer

    Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid Cancer

    G C A T T A C G G C A T genes Review Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid Cancer Kinga Hi ´ncza 1,* , Artur Kowalik 1 and Aldona Kowalska 2,3 1 Department Molecular Diagnostics, Holycross Centre, 25-734 Kielce, Poland 2 The Faculty of Health Sciences of the Jan Kochanowski University, 25-317 Kielce, Poland 3 Endocrinology Clinic of Holycross Cancer Centre, 25-734 Kielce, Poland * Correspondence: [email protected]; Tel.: +48-4136-742-58 Received: 16 May 2019; Accepted: 25 June 2019; Published: 26 June 2019 Abstract: The thyroid is the most common site of endocrine cancer. One type of thyroid cancer, non-medullary thyroid cancer (NMTC), develops from follicular cells and represents approximately 90% of all thyroid cancers. Approximately 5%–15% of NMTC cases are thought to be of familial origin (FNMTC), which is defined as the occurrence of the disease in three or more first-degree relatives of the patient. It is often divided into two groups: Syndrome-associated and non-syndromic. The associated syndromes include Cowden syndrome, familial adenomatous polyposis, Gardner syndrome, Carney complex and Werner syndrome. The hereditary factors contributing to the unfavorable course of FNMTC remain poorly understood; therefore, considerable effort is being expended to identify contributing loci. Research carried out to date identifies fourteen genes (DICER1, FOXE1, PTCSC2, MYH9, SRGAP1, HABP2, BRCA1, CHEK2, ATM, RASAL1, SRRM2, XRCC1, TITF-1/NKX2.1, PTCSC3) associated with vulnerability to FNMTC that are not related to hereditary syndromes. In this review, we summarize FNMTC studies to date, and provide information on genes involved in the development of non-syndromic familial non-medullary thyroid cancers, and the significance of mutations in these genes as risk factors.
  • HABP2 Sirna (Human)

    HABP2 Sirna (Human)

    For research purposes only, not for human use Product Data Sheet HABP2 siRNA (Human) Catalog # Source Reactivity Applications CRH2056 Synthetic H RNAi Description siRNA to inhibit HABP2 expression using RNA interference Specificity HABP2 siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression. Form Lyophilized powder Gene Symbol HABP2 Alternative Names HGFAL; PHBP; Hyaluronan-binding protein 2; Factor VII-activating protease; Factor seven-activating protease; FSAP; Hepatocyte growth factor activator-like protein; Plasma hyaluronan-binding protein Entrez Gene 3026 (Human) SwissProt Q14520 (Human) Purity > 97% Quality Control Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency. Components We offers pre-designed sets of 3 different target-specific siRNA oligo duplexes of human HABP2 gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot. Our siRNA oligos are also chemically modified (2’-OMe) at no extra charge for increased Application key: E- ELISA, WB- Western blot, IH- Immunohistochemistry,